← Browse by Condition
Medical Condition

adjuvant therapy

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for adjuvant therapy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — adjuvant therapy Clinical Trials

How many clinical trials are currently recruiting for adjuvant therapy?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for adjuvant therapy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for adjuvant therapy?
adjuvant therapy research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a adjuvant therapy clinical trial?
Eligibility criteria for adjuvant therapy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Phase 3
1
Top Sponsors
Kuirong Jiang 1 trial
Guo Xufeng 1 trial
Sichuan University 1 trial
Fudan University 1 trial
West China Hospital 1 trial

Recruiting Clinical Trials

NCT06361316
Recruiting
Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
Enrollment
53 pts
Location
China
Sponsor
Kuirong Jiang
View Trial →
NCT06056336 Phase 2
Recruiting
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
Enrollment
73 pts
Location
China
Sponsor
Guo Xufeng
View Trial →
NCT06344156 Phase 1
Recruiting
Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer
Enrollment
43 pts
Location
China
Sponsor
Sichuan University
View Trial →
NCT07019363 Phase 3
Recruiting
CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)
Enrollment
1,903 pts
Location
China
Sponsor
Fudan University
View Trial →
NCT06950814
Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
Enrollment
50 pts
Location
China
Sponsor
West China Hospital
View Trial →
NCT07622836
Recruiting
A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.
Enrollment
59 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →

Related Conditions

pancreatic cancer (2) esophageal squamous cell carcinoma (1) neoadjuvant chemoimmunotherapy (1) breast cancer (1) sarcomatoid carcinoma (1) liver cancer (1) tnbc (1) lymph node positive (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology